Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study
Authors:
- Carsten SchmidtCSCarsten Schmidt
- on behalf of the EPICOL Study GroupOGon behalf of the EPICOL Study Group
Open Access
- 27 January 2022
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 37 (2) , 485-493
Abstract
Purpose: The clinical course of ulcerative colitis (UC) is highly heterogeneous, with 20 to 30% of patients experiencing chronic disease activity requiring immunosuppressive or biologic therapies. The aim of this study was to identify predictors for a complicated disease course in an inception cohort of patients with UC. Methods: EPICOL was a prospective, observational, inception cohort (UC diagnosis, ≤ 6 months) study in 311 patients with UC who were naive to immunosuppressants (IS)/biologics. A complicated course of disease was defined as the need for IS and/or biologic treatment (here therapy with a TNF-α antagonist) and/or UC-related hospitalisation. Patients were followed up for 24 months. Results: Of the 307 out of 311 participants (4 patients did not meet the inclusion criteria “confirmed diagnosis of active UC within the last 6 months” (n = 2) and “immunosuppressive-naïve” (n = 2), analysis population), 209 (68.1%) versus 98 (31.9%) had an uncomplicated versus a complicated disease course, respectively. In a multivariate regression analysis, prior use of corticosteroids and prior anaemia were associated with a significantly increased risk for a complicated disease course (2.3- and 1.9-fold increase, respectively; p < 0.001 and p = 0.002). Based on these parameters, a risk model for patient stratification was developed. Conclusion: Our study identifies anaemia and an early need for corticosteroids as predictors for a complicated course of disease in an inception cohort of patients with UC. By determining these parameters in routine clinical practice, our results may support the identification of patients who might benefit from early escalation of therapy.Keywords
Funding Information
- Universitätsklinikum Jena
This publication has 36 references indexed in Scilit:
- Proximal disease extension and related predicting factors in ulcerative proctitisScandinavian Journal of Gastroenterology, 2013
- Cumulative Incidence and Risk Factors for Hospitalization and Surgery in a Population-based Cohort of Ulcerative ColitisInflammatory Bowel Diseases, 2013
- Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and futureAlimentary Pharmacology & Therapeutics, 2013
- Ulcerative Colitis as A Progressive Disease: The Forgotten EvidenceInflammatory Bowel Diseases, 2012
- Review of the disease course among adult ulcerative colitis population-based longitudinal cohortsInflammatory Bowel Diseases, 2012
- Simple score to identify colectomy risk in ulcerative colitis hospitalizationsInflammatory Bowel Diseases, 2010
- Predictors of corticosteroid‐dependent and corticosteroid‐refractory inflammatory bowel disease: analysis of a Chinese cohort studyAlimentary Pharmacology & Therapeutics, 2009
- History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitisInflammatory Bowel Diseases, 2009
- Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)Scandinavian Journal of Gastroenterology, 2009
- Low Colectomy Rates in Ulcerative Colitis in an Unselected European Cohort Followed for 10 YearsGastroenterology, 2007